Compare EWBC & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EWBC | SNN |
|---|---|---|
| Founded | 1998 | 1856 |
| Country | United States | United Kingdom |
| Employees | 3400 | 16988 |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 14.3B |
| IPO Year | 1998 | N/A |
| Metric | EWBC | SNN |
|---|---|---|
| Price | $123.05 | $30.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 2 |
| Target Price | ★ $131.14 | $36.25 |
| AVG Volume (30 Days) | 770.2K | ★ 1.3M |
| Earning Date | 04-21-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.57% | 2.48% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 2.57 | N/A |
| Revenue | ★ $55,316,000.00 | N/A |
| Revenue This Year | $13.49 | $8.58 |
| Revenue Next Year | $5.78 | $5.60 |
| P/E Ratio | ★ $47.87 | $64.97 |
| Revenue Growth | ★ 3.12 | N/A |
| 52 Week Low | $88.98 | $28.40 |
| 52 Week High | $127.52 | $38.79 |
| Indicator | EWBC | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 45.77 |
| Support Level | $103.51 | $29.08 |
| Resistance Level | $123.82 | $33.89 |
| Average True Range (ATR) | 2.31 | 0.55 |
| MACD | -0.35 | 0.17 |
| Stochastic Oscillator | 60.73 | 58.47 |
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.